[1] |
GIACCONE G. Clinical perspectives on platinum resistance[J]. Drugs,2000,59(Supplement 4):9-17. doi: 10.2165/00003495-200059004-00002 |
[2] |
颜冬梅, 屠凌岚, 彭小英, 等. 铂类抗癌新药双环铂的体内外抗肿瘤活性[J]. 中国现代应用药学杂志, 2007, 10(5):353. |
[3] |
LI G Q, CHEN X G, WU X P, et al. Effect of dicycloplatin, a novel platinum chemotherapeutical drug, on inhibiting cell growth and inducing cell apoptosis[J]. PLoS One,2012,7(11):e48994. doi: 10.1371/journal.pone.0048994 |
[4] |
闫长会, 施畅, 李玉风, 等. 新铂类药物双环铂与顺铂、卡铂体内毒性的比较研究[J]. 中国新药杂志, 2005, 14(10):1156-1159. doi: 10.3321/j.issn:1003-3734.2005.10.010 |
[5] |
CHANG H Y, CHANG S, YU F L, et al. Comparison of toxicities of bicycloplatin with cisplatin and carboplatin[J]. Chin J New Drugs,2005,14:1156-1159. |
[6] |
MILLER A B, HOOGSTRATEN B, STAQUET M, et al. Reporting results of cancer treatment[J]. Cancer,1981,47(1):207-214. doi: 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 |
[7] |
CHEN Y M, PERNG R P, LEE Y C, et al. Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: A randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated[J]. Ann Oncol,2002,13(1):108-115. doi: 10.1093/annonc/mdf009 |
[8] |
曾赟, 史美祺, 周国仁, 等. 双环铂联合紫杉醇治疗晚期非小细胞肺癌的Ⅱ期随机双盲多中心临床研究[J]. 南通大学学报(医学版), 2011, 31(5):327-329. doi: 10.3969/j.issn.1674-7887.2011.05.005 |
[9] |
林飞, 吕廉, 杨旭清, 等. 双环铂及其衍生物对大鼠靶器官毒性损伤的比较[J]. 癌变. 畸变. 突变, 2005, 17(5):276-279. |